Former DEA Chief of Pharmaceutical Investigations leading Khiron's best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated
Growth Capitalist (https://growthcapitalist.com/2018/06/khiron-vp-compliance-matt-murphy-appears-on-cbs-networks-60-minutes-to-discuss-law-enforcement-and-the-global-opioid-crisis/)
Former DEA Chief of Pharmaceutical Investigations leading Khiron's best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated